Related Experiment Videos
[Postpartum birth control: state-of-the-art]
G Robin1, P Massart, F Graizeau
1Service de gynécologie-obstétrique, centre hospitalier d'Armentières, rue Sadi-Carnot, 59280 Armentières, France. geoffroy.robin@laposte.net
Gynecologie, Obstetrique & Fertilite
|June 14, 2008
Summary
Postpartum contraception is crucial as ovulation can occur soon after delivery. Healthcare providers should offer updated contraceptive information and options before patients leave the maternity ward to prevent unintended pregnancies.
Area of Science:
- Obstetrics and Gynecology
- Reproductive Health
- Family Planning
Context:
- Menstrual flow typically resumes six weeks postpartum, but ovulation can occur as early as 25 days after delivery.
- Postpartum contraception is essential and requires proactive management in maternity wards.
- Healthcare providers must offer updated information on various contraceptive methods.
Purpose:
- To review and update medical practices regarding postpartum contraception.
- To emphasize the importance of diagnosing risk factors and prescribing suitable contraceptive options before hospital discharge.
- To simplify the contraceptive prescription process and reduce unwanted pregnancies.
Summary:
- Combined oral contraceptives with low dosages are safe for women without additional risk factors, posing no increased risk of deep venous thrombosis or significant breastfeeding disruption.
- Low-dose progestin-only pills are a safe option during lactation.
- Intrauterine devices (IUDs) can be inserted 4-6 weeks postpartum, or even immediately after delivery in certain cases, including during cesarean sections.
Impact:
- Facilitates informed decision-making for postpartum women regarding contraception.
- Empowers healthcare providers to offer timely and effective contraceptive solutions.
- Aims to decrease the incidence of unintended pregnancies in the postpartum period.
Related Concept Videos
01:22Birth Control Methods
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although vasectomy...
01:21Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
01:28Development of the Oral Microbiota
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
01:26Oral Drug Delivery Systems: Continuous-Release Systems
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
01:30Hormonal Control of the Ovarian Cycle
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
01:19Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...